Awm Investment Company, Inc. Nuvation Bio Inc. Transaction History

Awm Investment Company, Inc.

$650 Million
Q2 2024

A detailed history of Awm Investment Company, Inc. transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Awm Investment Company, Inc. holds 1,350,000 shares of NUVB stock, worth $3.16 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

1,350,000

Previous 1,350,000 -0.0%

Holding current value

$3.16 Million

Previous $4.91 Million 19.78%

% of portfolio

0.61%

Previous 0.73%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.96 - $1.53 $72,000 - $114,750	-75,000 Reduced 5.26%	1,350,000 $2.04 Million
Q2 2023 Aug 11, 2023	SELL	$1.56 - $1.84 $156,000 - $184,000	-100,000 Reduced 6.56%	1,425,000 $2.57 Million
Q1 2023 May 12, 2023	BUY	$1.6 - $2.48 $1.44 Million - $2.23 Million	900,000 Added 144.0%	1,525,000 $2.53 Million
Q4 2022 Feb 14, 2023	BUY	$1.68 - $2.5 $453,600 - $675,000	270,000 Added 76.06%	625,000 $1.2 Million
Q3 2022 Nov 14, 2022	BUY	$0.29 - $4.04 $4,350 - $60,600	15,000 Added 4.41%	355,000 $795,000
Q2 2022 Aug 12, 2022	SELL	$3.24 - $5.85 $194,400 - $351,000	-60,000 Reduced 15.0%	340,000 $1.1 Million
Q1 2022 May 13, 2022	SELL	$4.6 - $8.83 $1.38 Million - $2.65 Million	-300,000 Reduced 42.86%	400,000 $2.1 Million
Q4 2021 Feb 14, 2022	BUY	$7.75 - $10.05 $2.33 Million - $3.02 Million	300,000 Added 75.0%	700,000 $5.95 Million
Q3 2021 Nov 15, 2021	SELL	$7.78 - $10.0 $358,066 - $460,240	-46,024 Reduced 10.32%	400,000 $3.98 Million
Q2 2021 Aug 13, 2021	BUY	$9.22 - $14.48 $94,044 - $147,696	10,200 Added 2.34%	446,024 $4.15 Million
Q1 2021 May 13, 2021	BUY	$9.0 - $14.57 $3.92 Million - $6.35 Million	435,824 New	435,824 $4.55 Million

Others Institutions Holding NUVB

# of Institutions

152

Shares Held

123M

Call Options Held

9.7K

Put Options Held

6.5K

View Full List

About Nuvation Bio Inc.

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $508M
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

More about NUVB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Awm Investment Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Awm Investment Company, Inc. with notifications on news.

Account

Awm Investment Company, Inc. Nuvation Bio Inc. Transaction History